Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan
· Delayed Price · Currency is TWD 30.00
-0.05 (-0.17%)
Jun 6, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Injection | 630.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Injection Growth | 6.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| OEM and Others | 290.36M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| OEM and Others Growth | -26.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Preparation | 67.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Preparation Growth | -21.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| External Use | 36.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| External Use Growth | 0.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Equipment | 35.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Equipment Growth | -1.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Taiwan | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | -7.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 10.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 13.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|